"Remain Encouraged by VBI-1901's Performance" - Oppenheimer Reiterates VBI Vaccines (VBIV) at Outperform with $8 Price Target

Go back to "Remain Encouraged by VBI-1901's Performance" - Oppenheimer Reiterates VBI Vaccines (VBIV) at Outperform with $8 Price Target
(NASDAQ: VBIV) Delayed: 0.07 --0 (-0%)
Previous Close $0.07    52 Week High $4.35 
Open $0.07    52 Week Low $1.76 
Day High $0.07    P/E N/A 
Day Low $0.07    EPS $0.00 
Volume 4,298